News
Symbion, an owner and operator of short-stay surgical facilities headquartered in Nashville, Tenn., announced yesterday that it plans to issue an aggregate principal amount of $350 million of senior ...
Australia's Symbion Health Ltd <SYB.AX> has refused to let Healthscope Ltd <HSP.AX> and Primary Health Care Ltd <PRY.AX> talk to each other about breaking a stalemate in their rival takeover ...
Symbion reported $142.2 million in revenue for the second quarter of 2014. Here are five things to know about the company’s financial report. 1. The company’s revenue was up 7.5 percent from $132.3 ...
Symbion shares rose 1 cent at A$4.08 during Sydney trading, while Primary shares were in a trading halt having last traded at A$10.22. Primary’s offer is scheduled to close on February 21.
Nashville-based Symbion, which operates a chain of ambulatory surgery centers, is being purchased by a competitor for $792 million. The new buyer, Surgery Center Holdings Inc., is an affiliate of ...
Symbion (SMBI) today announced it has added to its portfolio of surgery centers three additional facilities in Indiana, Louisiana and Ohio. Terms of the transactions were not disclosed.
Chicago-based Surgery Partners plans to acquire Symbion for $792 million, a move that will add to consolidation in the physician surgery center market.
April 24 (Reuters) - Symbion Inc. , which runs short-stay surgery centers, said it has agreed to be bought by a private equity firm for about $486 million. New York-based Crestview Partners L.P ...
H.I.G. Capital's Surgery Center Holdings Inc. agreed to buy ambulatory surgery center operator Symbion Holdings Corp. from Crestview Partners for $792 million. The sale price translates to over ...
Primary Health Care, founded by Ed Bateman, revealed on Monday evening that it had built up an initial 5.25 per cent holding in Symbion and had proposed a $4.2 billion-plus merger with the company ...
TAKEOVER target Symbion Health has spurned outright Primary Health Care's highly conditional $2.65 billion cash offer as inferior to what is already on the table from Healthscope.
Symbion, the Australian healthcare group, vowed to continue its plans to merge with Healthscope after the A$2.9bn ($2.4bn) deal was blocked by rival suitor Primary Health Care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results